Literature DB >> 12542740

Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe.

C S Witt1, P Price, G Kaur, K Cheong, U Kanga, D Sayer, F Christiansen, N K Mehra.   

Abstract

The aim of this study was to determine whether a common diabetic haplotype, including human leukocyte antigen (HLA)-B8 and HLA-DR3, in Northern India is the same haplotype as the European HLA-B8-DR3 haplotype. DNA samples from Northern Indian subjects selected on the basis of HLA-B8 and HLA-DR3 were tested for microsatellite and single nucleotide polymorphism alleles throughout the major histocompatibility complex (MHC). It was found that the Indian samples represent a conserved haplotype in which all alleles were shared by Indian subjects with HLA-B8 and HLA-DR3, but were different to those that are characteristic of the European 8.1 ancestral haplotype. The Indian and European haplotypes share HLA-B*0801, HLA-DRB1*0301 and HLA-DQB1*02 but differ for subtypes of HLA-Cw*07 and HLA-DRB3 and all central MHC alleles tested. In contrast, Indian subjects selected on the basis of HLA-B58 ( 1-17) and HLA-DR3 shared the same alleles at other MHC loci as have been described in the common Chinese haplotype with HLA-B58/17 and HLA-DR3. A third haplotype, HLA-B50/21 and HLA-DR3, was also found to be highly conserved but shares little in common with the other two HLA-DR3-containing Indian haplotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12542740     DOI: 10.1034/j.1399-0039.2002.600602.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  17 in total

1.  Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Authors:  Christopher P Desmond; Silvana Gaudieri; Ian R James; Katja Pfafferott; Abha Chopra; George K Lau; Jennifer Audsley; Caroline Day; Sarah Chivers; Adam Gordon; Peter A Revill; Scott Bowden; Anna Ayres; Paul V Desmond; Alexander J Thompson; Stuart K Roberts; Stephen A Locarnini; Simon A Mallal; Sharon R Lewin
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  HLA and disease.

Authors:  Yogita Ghodke; Kalpana Joshi; Arvind Chopra; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  The roles of MHC class II genes and post-translational modification in celiac disease.

Authors:  Ludvig M Sollid
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

4.  Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.

Authors:  Silvana Gaudieri; Andri Rauch; Lawrence P Park; Elizabeth Freitas; Susan Herrmann; Gary Jeffrey; Wendy Cheng; Katja Pfafferott; Kiloshni Naidoo; Russell Chapman; Manuel Battegay; Rainer Weber; Amalio Telenti; Hansjakob Furrer; Ian James; Michaela Lucas; Simon A Mallal
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

5.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

6.  Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.

Authors:  Monika Tschochner; Abha Chopra; Tanya M Maiden; Imran F Ahmad; Ian James; Hansjakob Furrer; Huldrych F Günthard; Simon Mallal; Andri Rauch; Mina John
Journal:  Antivir Ther       Date:  2009

7.  IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.

Authors:  Vijayaprakash Suppiah; Silvana Gaudieri; Nicola J Armstrong; Kate S O'Connor; Thomas Berg; Martin Weltman; Maria Lorena Abate; Ulrich Spengler; Margaret Bassendine; Gregory J Dore; William L Irving; Elizabeth Powell; Margaret Hellard; Stephen Riordan; Gail Matthews; David Sheridan; Jacob Nattermann; Antonina Smedile; Tobias Müller; Emma Hammond; David Dunn; Francesco Negro; Pierre-Yves Bochud; Simon Mallal; Golo Ahlenstiel; Graeme J Stewart; Jacob George; David R Booth
Journal:  PLoS Med       Date:  2011-09-13       Impact factor: 11.069

8.  Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection.

Authors:  Shuo Li; Stefan Floess; Alf Hamann; Silvana Gaudieri; Andrew Lucas; Margaret Hellard; Stuart Roberts; Geza Paukovic; Magdalena Plebanski; Bruce E Loveland; Campbell Aitken; Simon Barry; Louis Schofield; Eric J Gowans
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

9.  Segregation Analysis of Genotyped and Family-Phased, Long Range MHC Classical Class I and Class II Haplotypes in 5 Families With Type 1 Diabetes Proband in the United Arab Emirates.

Authors:  Guan K Tay; Halima Al Naqbi; Aurélie Mawart; Zahrah Baalfaqih; Anoud Almaazmi; Asma Deeb; Habiba Alsafar
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

10.  HLA class II SNP interactions and the association with type 1 diabetes mellitus in Bengali speaking patients of Eastern India.

Authors:  Oindrila Raha; Biswanath Sarkar; Bhaskar V K S Lakkakula; Veerraju Pasumarthy; Sudhakar Godi; Subhankar Chowdhury; Pradip Raychaudhuri; Raghavendra Rao Vadlamudi
Journal:  J Biomed Sci       Date:  2013-02-27       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.